Uncategorised - International Biopharmaceutical Industry

Current Edition

Issue 9, Volume 3

Current Features

Issue 9, Volume 3

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Uncategorised

Arrowhead shares soar on liver disease data from four patients

Shares in Arrowhead Pharmaceuticals rose by nearly 50% Wednesday after the California-based biotech said its drug for a rare liver disease reduced levels of a mutant ...

21 September 2020 Uncategorised

Continue Reading →

Uncategorised

Product characterization: Reveal your molecule earlier, faster, and with accuracy

Product characterization can be challenging throughout drug development because it requires advanced technologies and specialized expertise. Thus, it is vital to star...

21 October 2019 Uncategorised | news

Continue Reading →

news

Former FDA chief Gottlieb predicts Trump-pitched pricing model easy to game

As President Donald Trump's International Pricing Index slogs through the regulatory process, former Food and Drug Administration head Scott Gottlieb predicted Monday...

11 October 2019 news | Uncategorised

Continue Reading →

news

With new report, ICER puts itself at center of drug pricing storm

Pharmaceutical companies often preach value. Yet, for seven top-selling drugs, prices went up in 2017 and 2018 despite limited new evidence showing patients receiving...

11 October 2019 news | Uncategorised

Continue Reading →

news

MilliporeSigma Acquires FloDesign Sonics for Acoustic Technology for Cell Therapy

MilliporeSigma announced it has acquired FloDesign Sonics, a Wilbraham, MA-based acoustic cell processing platform developer for the industrialization of cell and gen...

11 October 2019 news | Uncategorised

Continue Reading →

news

Gene therapy biotechs caught in manufacturing crunch

Rapidly progressing gene therapy development could push more biotechs to invest in their own manufacturing capabilities over outsourcing to contract services companie...

11 October 2019 news | Uncategorised

Continue Reading →

news

Treatment of pain and inflammation with Tetra Bio-Pharma’s CAUMZ kit

CAUMZ is a non-opioid alternative in Phase 3 development for the treatment of pain and inflammation, and Tetra are one step closer to bringing the kit to market. CAUM...

11 October 2019 news | Uncategorised

Continue Reading →

news

Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim Chief Medical Officer

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-thre...

11 October 2019 news | Uncategorised

Continue Reading →

news

Over 80 Iconic Landmarks to Light Up in Unity Across the Globe to Raise Awareness for Stage IV Metastatic Breast Cancer in October

Moore Fight Moore Strong (MFMS) – an organization with a mission to carry on the legacy of their best friend, Jessica Moore, to raise awareness for Metastatic Breast...

11 October 2019 news | Uncategorised

Continue Reading →

news

Biogen’s R&D head is out, following string of clinical setbacks

Biogen has a new R&D leader, announcing Tuesday that Michael Ehlers will leave on Oct. 11 and, effective immediately, pass his duties on to Chief Medical Officer ...

7 October 2019 news | Uncategorised

Continue Reading →